CAS NO: | 1448314-31-5 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
neutrophil elastase inhibitor
Cas No. | 1448314-31-5 |
化学名 | 1-(3-methylbenzoyl)-1H-indazole-3-carbonitrile |
Canonical SMILES | O=C(C1=CC=CC(C)=C1)N2C3=CC=CC=C3C(C#N)=N2 |
分子式 | C16H11N3O |
分子量 | 261.3 |
溶解度 | ≤0.5mg/ml in ethanol;10mg/ml in DMSO;30mg/ml in dimethyl formamide |
储存条件 | Store at -20℃ |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
文献引用 | |
产品描述 | IC50: 7 nM Neutrophil Elastase Inhibitor is a neutrophil elastase inhibitor. Human neutrophil elastase (HNE) is a member of the chymotrypsin superfamily of serine proteases that is involved in the response to inflammatory stimuli. HNE is reported to be stored in azurophilic granules of neutrophils and is greatly aggressive and cytotoxic, as its substrates include various components of the extracellular matrix. In vitro: Previous study found that Neutrophil Elastase Inhibitor was able to inhibit thrombin and urokinase at micromolar concentrations. In addition, Neutrophil Elastase Inhibitor appeared to be a specific HNE inhibitors in a competitive manner. Moreoer, the hydrolysis of the acyl-enzyme complex for Neutrophil Elastase Inhibitor was found to be much slower than spontaneous hydrolysis of Neutrophil Elastase Inhibitor, and HNE was observed to be still inhibited to 80% of control level at 7 h after treatment [1]. In vivo: So far, there is no animal in vivo data reported. Clinical trial: Up to now, Neutrophil Elastase Inhibitor is still in the preclinical development stage. References: |